You are about to leave jnjmedicaldevices.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Biosense Webster – Health Economics & Outcomes Research
AF Burden of Disease and Treatment
As a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, Biosense Webster, Inc. is committed to patient advocacy and raising awareness of atrial fibrillation and its available treatment options.
Atrial Fibrillation Burden of Disease Report
The AF Burden of Disease Report outlines the growing burden of AF on patients, caregivers and healthcare systems across Europe, emphasizing the scale and impact of the disease.
Atrial Fibrillation Management Report
The Atrial Fibrillation Management Report details current guideline-recommended treatment options for AF as well as their long-term impact on clinical, patient and economic outcomes, aiming to support healthcare professionals (HCPs) when making treatment decisions.
Burden of AF
Full Report: The Burden of Atrial Fibrillation
The Burden of Atrial Fibrillation: Executive Summary of 2018 Report
The Burden of Atrial Fibrillation: infographic
Infographic: The New Millennium Epidemic of Atrial Fibrillation
Management of AF
Atrial Fibrillation Management: 2019 Full Report
Atrial Fibrillation Management: 2019 Executive Summary
Atrial Fibrillation Management: Infographic